Clinical analysis of anti-Ma2-associated encephalitis.
暂无分享,去创建一个
M. Rosenfeld | J. Dalmau | J. Posner | A. Saiz | P. Meneses | D. Blumenthal | F. Graus | A. Villarejo | B. Thiessen
[1] E. Mignot,et al. Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis , 2004, Neurology.
[2] J. Landolfi,et al. Paraneoplastic limbic encephalitis and possible narcolepsy in a patient with testicular cancer: case study. , 2003, Neuro-oncology.
[3] P. Wen,et al. Neurologic Complications of Cancer , 2003 .
[4] E. Mignot,et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. , 2002, Archives of neurology.
[5] M. Rosenfeld,et al. Molecular and clinical diversity in paraneoplastic immunity to Ma proteins , 2001, Annals of neurology.
[6] R. Tomlinson,et al. Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates , 2001, Journal of the Neurological Sciences.
[7] G. Escaramís,et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. , 2001, Brain : a journal of neurology.
[8] T. Jonges,et al. Testicular microlithiasis, a premalignant condition: prevalence, histopathologic findings, and relation to testicular tumor. , 2001, Urology.
[9] M. Magistris,et al. Paraneoplastic anti‐CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy , 2001, Annals of neurology.
[10] G. M. Halmágyi,et al. Paraneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody , 2001, Journal of neurology, neurosurgery, and psychiatry.
[11] J. Dalmau,et al. Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies , 2000, Neurology.
[12] J. Dalmau,et al. Limbic encephalitis and antibodies to Ma2: a paraneoplastic presentation of breast cancer , 2000, Journal of neurology, neurosurgery, and psychiatry.
[13] S. Gultekin,et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. , 2000, Brain : a journal of neurology.
[14] J. Gligorov,et al. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. , 1999, The New England journal of medicine.
[15] Z. Mourelatos,et al. Neuro-ophthalmologic manifestations of a paraneoplastic syndrome and testicular carcinoma , 1999, Neurology.
[16] H. Alagöl,et al. Germinal cell tumors of the testis in cryptorchids. , 1998, Journal of experimental & clinical cancer research : CR.
[17] E. Dropcho. Neurologic paraneoplastic syndromes , 1998, Journal of the Neurological Sciences.
[18] J. Honnorat,et al. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[19] R. Sawaya,et al. Neurologic Complications of Cancer. , 1996 .
[20] P. Burger,et al. Paraneoplastic limbic encephalopathy with testicular carcinoma: A reversible neurologic syndrome , 1988, Cancer.
[21] I. Janota,et al. The late effects of necrotizing encephalitis of the temporal lobes and limbic areas: a clinico-pathological study of 10 cases , 1978, Psychological Medicine.
[22] R. Wyburn-Mason. Cancer and the Nervous System , 1969 .
[23] S. Gultekin,et al. Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. , 1999, Brain : a journal of neurology.
[24] R. Layzer. Cancer and the nervous system. , 1969, California medicine.